Tribal Group Plc · LSE:TRB

Tribal — Investor Presentation (February 2006)

21 slides from Tribal's investor presentation, Feb 14, 2006

  1. Slide 1: Mercury Health

    Mercury Health Presentation: 14 February 2006 Peter Martin - Chief Executive

  2. Slide 2: Contents

    Contents ƒ A. Market background ƒ B. Progress to date ƒ C. Future opportunities

  3. Slide 3: A. Market background

    Mercury Health A. Market background

  4. Slide 4: Market reform

    Market reform Payment By Results: PBR TRANSACTIONAL REFORMS Choose and Book BETTER CARE Foundation Trusts New Primary Care Trusts Independent Sector (ISTCs) Practice Based Commissioning BETTER PATIENT EXPERIENCE Voluntary/mutual organisations DEMAND SIDE REFORMS BETTER VALUE FOR MONEY SUPPLY SIDE RE

  5. Slide 5: Market drivers (ISTCs)

    Market drivers (ISTCs) ƒ Principal driver is choice / plurality of provision: ƒ Waiting lists / targets (18 weeks from referral to treatment by December 2008) ƒ Quality ƒ Efficiency ƒ Innovation ƒ Clinical ƒ Operational ƒ Implementation ƒ Additionality ƒ Infrastructure ƒ Staffing

  6. Slide 6: Market drivers (primary care)

    Market drivers (primary care) ƒ Again, choice is a major driver plurality of providers ƒ Services moving from acute hospitals to community / primary care ƒ PCT reform likely to lead to divestiture of provider functions ƒ Reform of GP services ƒ Ageing GP population ƒ Under-serviced areas ƒ Fragmente

  7. Slide 7: Market opportunities

    Market opportunities Opportunity Potential size Procurement status Phase 2 elective surgery ~£2.5bn. (over 5 years) Current Extended choice network £500mn. - £1bn. (over 5 years) Current Phase 2 diagnostics ~£1bn. (over 5 years) Current Primary care pilots £25 - 40mn. (over 5 years) Current Primary

  8. Slide 8: B. Progress to date

    Mercury Health B. Progress to date

  9. Slide 9: Introduction

    Introduction ƒ Mercury Health is 100 per cent. owned by Tribal Group plc ƒ Principal focus is delivering healthcare services to NHS patients ƒ Three business streams: ƒ Elective surgery ƒ Diagnostics ƒ Primary care ƒ Key clinical partnerships ƒ Health Inventures (US) - Clinical commissioning ƒ Hospi

  10. Slide 10: Management team

    Management team Executive team Chief Executive Peter Martin Tribal main board director Strategy Director Mark Smith Former NHS trust chief executive Finance Director Steve Breach Former Ernst & Young director Medical Director Patrick Beasley Former foundation trust medical director Clinical Services

  11. Slide 11: Elective surgery & diagnostics

    Elective surgery & diagnostics Centre Activity Open Annual revenue guarantee Wycombe Diagnostic imaging centre August 2005 £2.0mn. Medway Daycase surgery October 2005 £5.0mn. Portsmouth Daycase surgery, diagnostics December 2005 £13.0mn. and MIU / walk-in centre Haywards Heath Elective orthopaedic c

  12. Slide 12: Portsmouth

    Portsmouth ƒ Commissioning ƒ Facility built, equipped and staffed in less than 12 months from contract close ƒ Opened on time and to budget ƒ Total staff of 84 ƒ Surgery ƒ Four operating theatres; minimum capacity of 6,800 procedures per annum ƒ Hungarian and UK surgeons ƒ Diagnostics ƒ X-ray and ul

  13. Slide 13: Primary care

    Primary care ƒ Mercury Health Primary Care (“MHPC”) established in late 2005 ƒ Initial management team recruited ƒ Affiliation with Chilvers McCrea ƒ Run nearly 20 GP practices ƒ Preferred bidder on new walk-in centre ƒ Collaborating with MHPC on primary care developments ƒ Affiliation with Frome Me

  14. Slide 14: Financial summary

    Financial summary ƒ Implementation and construction costs ƒ To date, costs incurred are in line with expectations ƒ Forecast is to remain within budget through to completion ƒ Revenue (assuming no new business wins) Year end 31 March 2006 2007 2008 Revenue (£000) 13,500* 34,000 39,000 * Includes int

  15. Slide 15: C. Future opportunities

    Mercury Health C. Future opportunities

  16. Slide 16: Phase 2 elective surgery

    Phase 2 elective surgery ƒ ~£2.5bn. programme covering 24 schemes ƒ Broad range of services but emphasis on orthopaedics and general surgery ƒ Programme being procured in a number of tranches ƒ Mercury Health shortlisted on two schemes in the first tranche ƒ Further tranches due over the next 3-4 mo

  17. Slide 17: Phase 2 diagnostics

    Phase 2 diagnostics ƒ ~£1bn. programme covering eight schemes ƒ Diagnostic imaging, endoscopy and physiological measurements ƒ Mercury Health shortlisted on three regional contracts ƒ Partnering with a Foundation Trust in each region ƒ First preferred bidders expected summer 2006 ƒ Early service del

  18. Slide 18: Phase 2 - contract issues

    Phase 2 - contract issues ƒ Same contractual structure for elective surgery and diagnostics ƒ Five year contracts with an option for a two year extension ƒ Providers required to take (some) demand risk ƒ Additionality relaxed but remains for ‘shortage professions’ ƒ Residual value payments will unde

  19. Slide 19: Phase 2 - funding

    Phase 2 - funding ƒ Scale of funding will be determined by the level of contractual success ƒ Four principal requirements for funding anticipated: ƒ Construction – non-recourse senior debt supported by residual values ƒ Equipment – principally, operating leases ƒ Implementation – Tribal equity utili

  20. Slide 20: Primary care

    Primary care ƒ Shortlisted on six pilot schemes ƒ GP practices, walk-in centres, primary care services to care homes ƒ Preferred bidders expected summer 2006 ƒ Other opportunities ƒ Second wave schemes (late 2006?) ƒ Local opportunities ƒ GP practices ƒ Establish primary care services at Mercury Hea

  21. Slide 21: Conclusion

    Conclusion ƒ Mercury Health established as a significant healthcare delivery business ƒ Strong reputation: ƒ First visit by the Secretary of State to an ISTC ƒ Partners include leading national and international healthcare organisations ƒ Prominent representation on senior industry bodies ƒ Focus wi

Tribal Group — Investor Presentation (February 2006) on 6ix